As per the partnership, Alvotech will be responsible for development and supply of the product, whereas Cipla will be responsible for registration and commercialisation of the productfrom Moneycontrol Business News https://ift.tt/310P6Os
Sunday, July 28, 2019
Cipla, Iceland#39;s Alvotech ink pact to sell biosimilar Adalimumab in emerging markets
As per the partnership, Alvotech will be responsible for development and supply of the product, whereas Cipla will be responsible for registration and commercialisation of the productfrom Moneycontrol Business News https://ift.tt/310P6Os
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment